$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Applications and limitations
Drug self-administration is used in rodents to model drug addiction. Many drugs of abuse that are modeled in this fashion can be administered intravenously, in which the drug is delivered directly to the central compartment. This allows for close monitoring of dose over a self-administration session. Since ethanol is usually orally self-administered, it is much harder to monitor drug levels due to individual differences in absorption and metabolism. By using microdialysis to sample from the brain region of interest, we are not only able to monitor the pattern of ethanol reaching the region, but we are also able to simultaneously monitor neurotransmitter changes in the same region over time during each self-administration phase.
Neurochemical alterations and drug-induced responses in the brain are associated with drug abuse and dependence; thus, the ability to concurrently measure neurochemical and drug concentrations during specific self-administration phases provides a very powerful and unique tool. One issue to keep in mind for correlating dialysate concentrations of analytes with behavior is the physical characteristics of the microdialysis plumbing. Specifically, the time it takes for fluid to be transferred from the lumen of the microdialysis probe to the collection tube is critical, and shorter times are better. In our lab, we construct the probes so that the time is about 90 sec. Using these conditions, we have found that there is an accumbal dopamine increase at the initiation of ethanol consumption, which decreases over the course of the drink and post-drink periods as the dialysate ethanol concentration increases.2,3,8,9 These experiments, when combined with data from pharmacological studies, have allowed us to parse out the strictly pharmacological effects of ethanol and self-administration associated environmental cues on changes in neurotransmitter concentrations.
It should be noted that this particular application of combined behavioral-microdialysis techniques is suited to the current research interests of our laboratory. It is designed to evaluate the temporal pattern of ethanol reaching the brain in comparison to the pattern of neurotransmitter changes in the same region, so that we can relate these measures to synchronous self-administration behaviors. The derived dialysate ethanol concentrations are not corrected for in vivo probe recovery, and are only a fraction of the brain ethanol tissue concentration. If quantitative microdialysis of ethanol is required, the extraction fraction of ethanol that diffuses from the extracellular space into the probe should be experimentally determined. See previous publications from our laboratory for methods and further discussion.10,11,12
Although this protocol illustrates the use of gas chromatography along with solid phase microextraction of ethanol from the headspace of microdialysis samples, other methods for analysis of the ethanol content of the microdialysis sample could be used. However, alternative methods may suffer from some disadvantages. For example, less sensitive analytical methods may require a larger sample volume which necessitates sampling times greater than the 5-7 min illustrated here. The type of system discussed here uses a solid phase microextraction that concentrates the ethanol in the vapor phase in the sealed sample vial by allowing absorption to the fiber placed in the vial headspace. This improves the detection limit compared with direct headspace sampling which typically allows 50-100 μl of the vapor to be injected. Another major advantage of the headspace method is that the sample injected for analysis is extremely clean and free of salts. Direct injection of the liquid microdialysis sample may also be used with higher sensitivity, but this will require more instrument down time due to regular maintenance required for cleaning out the injected salts.
Trouble-shooting and other notes
- Before your experiment begins, give yourself plenty of time to check that your microdialysis set-ups are functioning properly and to trouble-shoot any issues. We suggest that you have an extra set-up, perfused with ACSF, ready to switch out with a malfunctioning set-up to save yourself time, as most operant sessions tend to occur at a specific time every day.
- Be sure that the microdialysis probes are inserted over a period of about 5 min to minimize the tissue damage produced by shearing of the tissue as the probe penetrates the brain.
- When transferring the rat into the operant chamber it is helpful to have a second person assist so that the transfer line (part of the microdialysis set-up) does not becoming tangled, and so that the operant program can be initiated on time.
- Make sure that you give the autosampler water bath plenty of time to reach the appropriate temperature. Our system typically requires two hr to reach 50 °C. Also, assure that your samples are fully vaporized before analyzing the samples. We typically visually confirm that this has occurred before initiating sample analysis.
- Standard good analytical chemistry practices should be followed. These include, but are not limited to, validation of individuals, equipment, and procedures. In brief, we employ the following guidelines: Individual users should demonstrate the ability to generate reproducible peak height values for standard concentrations and linear standard curves (R2 ≥ 0.99) across multiple days. To verify the GC-FID system is working correctly, standards should be always be analyzed before any dialysate samples are injected. The standard curve generated should have an R2 ≥ 0.99.
- Most of the equipment we use was purchased through Varian, Inc., which was acquired by Agilent Technologies in 2010. At this time, Bruker Scientific Instruments obtained Varian's laboratory gas chromatography instruments business. For future purchases, consult either company.
- The present protocol shows operant behavior with rats, but the viewer should be aware that more disruption of behavior is likely to occur with the smaller mouse model. Another issue to be aware of is that placement of a microdialysis probe into brain regions other than the medial prefrontal cortex or nucleus accumbens may disrupt operant behavior to a greater degree than shown here. It is important to closely examine numerous behavioral parameters to determine if the damage caused by probe placement produces severe changes in behavior.